NXL and NXLIW Related Headlines

Go Back

May 21, 2026 08:30AM Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of
May 19, 2026 08:30AM Nexalin acquires digital health platform for $1.3 million ahead of trial
May 19, 2026 08:30AM Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial
Apr 28, 2026 09:15AM Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
Apr 14, 2026 08:30AM Join Nexalin’s Exclusive Live Investor Webinar and Q&A Session on April 21
Apr 9, 2026 07:47AM Nexalin Announces Peer-Reviewed Study Showing the Company’s DIFS™ Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents
Feb 5, 2026 08:37AM Nexalin Launches NeuroCare®, an AI-Driven Virtual Clinic Designed to Transform Access for Patients with Alzheimer’s, Mood Disorders, TBI & PTSD Care
Dec 2, 2025 08:00AM Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4
Aug 25, 2025 09:00AM Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on September 9

NXL and NXLIW Related Press Releases

Go Back

May 21, 2026 08:30AM Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of
May 19, 2026 08:30AM Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial
Apr 28, 2026 09:15AM Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
Apr 14, 2026 08:30AM Join Nexalin’s Exclusive Live Investor Webinar and Q&A Session on April 21
Apr 9, 2026 07:47AM Nexalin Announces Peer-Reviewed Study Showing the Company’s DIFS™ Technology Reduced Self-Injury and Depression Symptoms in Female Adolescents
Feb 5, 2026 08:37AM Nexalin Launches NeuroCare®, an AI-Driven Virtual Clinic Designed to Transform Access for Patients with Alzheimer’s, Mood Disorders, TBI & PTSD Care
Dec 2, 2025 08:00AM Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4
Aug 25, 2025 09:00AM Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on September 9

NXL and NXLIW Related SEC Filings

Go Back